ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "risk assessment"

  • Abstract Number: 2492 • ACR Convergence 2024

    ANCA Associated Tracheobronchial Disease

    Megan Sullivan1, Maximiliano Diaz Menindez2, Ronald Butendieck3, hassan baig4, Anushka Irani5, Benjamin Wang3, Florentina Berianu5, Carolyn Mead-Harvey6, Andy Abril5 and Vikas Majithia4, 1Mayo Clinic Arizona, Scottsdale, AZ, 2Mayo Clinic School of Graduate Medical Education, Phoenix, AZ, 3Mayo Clinic, Jacksonville, FL, 4Mayo Clinic Florida, Jacksonville, FL, 5Mayo Clinic, Ponte Vedra Beach, FL, 6Mayo Clinic, Scottsdale, AZ

    Background/Purpose: Tracheobronchial disease is a common manifestation of ANCA associated vasculitis (AAV). However, outcomes data is commonly unreported in prospective studies. We performed a retrospective…
  • Abstract Number: 0306 • ACR Convergence 2024

    Cardiovascular Risk Estimated with the New PREVENT Calculator and Disease Activity in Patients with Rheumatoid and Psoriatic Arthritis

    Aleydis Gonzalez Melendez1, Rebeca L. Polina-Lugo1, Maria F. Elizondo-Benitez2, Andrea Guajardo Aldaco1, Osvaldo Uresti3, Ricardo I. de la Rosa-Vazquez3, Iris Jazmín Colunga Pedraza1, Dionicio Galarza-Delgado4, jose Ramon Azpiri-Lopez5, Rosa Icela Arvizu-Rivera1 and Jesus Cardenas-de la Garza6, 1Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 2Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 3Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 4UANL Hospital Universitario, Monterrey, Nuevo León, Mexico, 5Division of Cardiology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 6Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico

    Background/Purpose: The American Heart Association's PREVENT (Predicting Risk of Cardiovascular Disease EVENTs) is a new calculator developed in 2024, which estimates the 10- and 30-year…
  • Abstract Number: 1133 • ACR Convergence 2024

    Relationship Between Nail Psoriasis Severity Index (NAPSI) and Cardiovascular Risk Assessed by Eight Cardiovascular Risk Calculators

    Maria F. Elizondo-Benitez1, Iris Jazmín Colunga Pedraza2, jose Ramon Azpiri-Lopez3, Dionicio Galarza-Delgado4, Jesus Cardenas-de la Garza5, Rosa Icela Arvizu-Rivera2, Andrea Guajardo Aldaco2 and Valeria Gonzalez-Gonzalez6, 1Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 2Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 3Division of Cardiology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 4UANL Hospital Universitario, Monterrey, Nuevo León, Mexico, 5Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 6Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico

    Background/Purpose: Psoriatic arthritis (PsA) is a chronic, inflammatory, and immune-mediated disease that affects up to 30% of psoriasis (PsO) patients. Nail psoriasis affects 80% of…
  • Abstract Number: 1905 • ACR Convergence 2024

    Combining Three Peripheral Biomarkers to Stratify Rheumatoid Arthritis-Associated Interstitial Lung Disease Risk

    Bryant England1, Austin Wheeler1, Brent Luedders1, Michael Duryee1, Halie Frideres2, Katherine Wysham3, grant Cannon4, Gary Kunkel5, Dana Ascherman6, Paul Monach7, Gail Kerr8, Andreas Reimold9, Joshua Baker10, Geoffrey Thiele1 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE, 2UNMC Department of Rheumatology, Omaha, NE, 3VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA, 4University of Utah and Salt Lake City VA, Salt Lake City, UT, 5University of Utah and George E Wahlen VAMC, Salt Lake City, UT, 6Division of Rheumatology and Clinical Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, 7VA Boston Healthcare System, Boston, MA, 8Washington DC VAMC/Georgetown and Howard Universities, Washington, DC, 9Dallas VA Medical Center, Dallas, TX, 10Department of Medicine, Perelman School of Medicine University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Several peripheral biomarkers for RA-associated interstitial lung disease (RA-ILD) have been evaluated to enhance early RA-ILD identification. The MUC5B rs35705950 promoter variant, matrix metalloproteinase-7…
  • Abstract Number: 2635 • ACR Convergence 2024

    Direct to Patient Screening for Psoriatic Arthritis in Patients with Psoriasis: Appropriateness of Rheumatology Referrals and Treatment Outcomes

    Swetha Ann Alexander1, Shaobo Pei2, Gopi Penmetsa3, Soumya Reddy4, Jose Scher5, Alexis Ogdie6 and Jessica A Walsh7, 1University of Utah, Salt lake City, UT, 2University of Utah, Thousand Oaks, CA, 3University Of Utah Hospital, Salt Lake City, UT, 4NYU Grossman School of Medicine, New York, NY, 5New York University School of Medicine, New York, NY, 6Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 7Division of Rheumatology, Salt Lake City Veterans Affairs Health and University of Utah Health, Salt Lake City, UT

    Background/Purpose: Diagnostic delays in psoriatic arthritis (PsA) among psoriasis patients are common due to under recognition by referring providers. Previous studies show that a PsA…
  • Abstract Number: 0335 • ACR Convergence 2024

    Analysis of the Prevalence of Diabetes Mellitus in Patients with Adult-onset Dermatomyositis

    Komal Ejaz1, Chao Zhang2 and Soumya Chatterjee3, 1Cleveland Clinic, Cleveland, OH, 2Cleveland Clinic, Cleveland Heights, OH, 3Cleveland Clinic, Richmond Heights, OH

    Background/Purpose: Dermatomyositis is an idiopathic inflammatory myopathy with proximal muscle weakness and skin manifestations. Myositis patients have poor overall health partially due to co-morbidities. Data…
  • Abstract Number: 1151 • ACR Convergence 2024

    Clinical Characterization and Recurrence Prediction Model for Immune-Mediated Necrotizing Myopathy

    Beibei Cui1, Hongjiang Liu2, Geng Yin3 and Qibing Xie4, 1Rheumatology and Immunology, Chengdu, China (People's Republic), 2West China Hospital, Sichuan University, Chengdu, China (People's Republic), 3Department of Rheumatology and Immunology, chengdu, China (People's Republic), 4Department of Rheumatology and Immunology, Chengdu, Sichuan, China

    Background/Purpose: The primary objective of this study was to comprehensively analyze the clinical characteristics of immune-mediated necrotizing myopathy (IMNM) and develop a reliable recurrence prediction…
  • Abstract Number: 1918 • ACR Convergence 2024

    Exploring the Childhood Opportunity Index and Distance to Care in a Cohort of Children with Rheumatic Disease

    Kristina Ciaglia1 and Alaina Beauchamp2, 1UT Southwestern Medical Center and Scottish Rite for Children, Dallas, TX, 2UT Southwestern Medical Center, Dallas

    Background/Purpose: Children from disadvantaged neighborhoods and socioeconomic backgrounds experience worse outcomes and delays in care.¹ The Childhood Opportunity Index (COI) is a multidimensional validated tool…
  • Abstract Number: 0444 • ACR Convergence 2024

    Deep Serologic Profiling Identifies Novel Autoantibodies Associated with Fetal Atrioventricular Block

    Philip Carlucci1, Robert Clancy2, Mala Masson3, Colin Phoon4, Ashley Roman4, Peter Izmirly5, Amit Saxena6, H Michael Belmont4, Christina Penfield4, Young Mi Lee4, Julie Nusbaum7, Andrew Rubenstein4, Ruben Acherman8, Elena Sinkovskaya9, Alfred Abuhamad9, Karla Bermudez-Wagner9, Majd Makhoul10, Gary Satou11, Whitnee Hogan12, Nelangi Pinto13, Anita Moon-Grady14, Lisa Howley15, Mary Donofrio16, Anita Krishnan16, Jaclyn Phillips17, Stephanie Levasseur18, Miwa Geiger19, Erin Paul20, Sonal Owens21, Kristopher Cumbermack22, Jyothi Matta23, Gary Joffe24, Christopher Lindblade25, Carl Weiner26, Caitlin Haxel27, Katherine Kohari28, Joshua Copel28, James Strainic29, Tam Doan30, Shreya Sheth30, Stacy Killen31, Theresa Tacy32, Michelle Kaplinski32, Nicola Fraser4, Kelly Ruggles33, Bettina Cuneo34 and Jill Buyon35, 1New York University School of Medicine, New York, NY, 2Columbia University Medical Center, New York, NY, 3NYU Langone Medical Center- Division of Rheumatology, New York, NY, 4NYU Langone Health, New York, NY, 5New York University Grossman School of Medicine, New York, NY, 6NYU Grossman School of Medicine, New York, NY, 7NYU Langone Hospital - Long Island, Internal Medicine - Rheumatology, Mineola, NY, 8Children's Heart Center, Las Vegas, NV, 9Eastern Virginia Medical School, Norfolk, VA, 10Atrium Health Levine Children's Hospital, Charlotte, NC, 11University of California Los Angeles, Los Angeles, CA, 12University of Utah, Salt Lake City, UT, 13Seattle Children's Hospital, Seattle, WA, 14University of California San Francisco, San Francisco, CA, 15Midwest Fetal Care Center, Children's Minnesota/Allina Health, Minneapolis, MN, 16Children's National Hospital, Washington, DC, 17George Washington University, Washington, DC, 18Columbia University, New York, NY, 19Mount Sinai School of Medicine, New York, NY, 20Atlantic Health System, Morristown, NJ, 21University of Michigan, Ann Arbor, MI, 22University of Kentucky, Lexington, KY, 23University of Louisville, Louisville, KY, 24Perinatal Associates of New Mexico, Albuquerque, NM, 25Phoenix Children's Hospital, Phoenix, AZ, 26Dignity Health, Phoenix, AZ, 27University of Vermont Children's Hospital, Burlington, VT, 28Yale University, New Haven, CT, 29UH Rainbow Babies, Cleveland, OH, 30Baylor College of Medicine, Houston, TX, 31Vanderbilt University, Nashville, TN, 32Stanford University, Stanford, CA, 33NYU Grossman School of Medicine, Brooklyn, NY, 34University of Arizona College of Medicine, Tucson, AZ, 35New York University Grossman School of Medicine, New York, NY

    Background/Purpose: Maternal anti-SSA/Ro52/60kD autoantibodies are necessary for the development of fetal atrioventricular block (AVB) but titers alone are not sufficient to predict the likelihood of…
  • Abstract Number: 1192 • ACR Convergence 2024

    Relationship Between Measures of Fat Mass and Knee Osteoarthritis Incidence: The Multicenter Osteoarthritis (MOST) Study

    Kristine Godziuk1, Sarah Tilley2, mike LaValley3, Douglas Kiel4, Michael Nevitt5, C.E. Lewis6, James Torner7 and Tuhina Neogi2, 1University of Alberta, Edmonton, AB, Canada, 2Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 3Boston University School of Public Health, Arlington, MA, 4Hebrew SeniorLife and Department of Medicine Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, 5UCSF, Orinda, CA, 6University of Alabama at Birmingham, Birmingham, AL, 7University of Iowa, Iowa City

    Background/Purpose: Obesity [defined by body mass index (BMI) ≥30 kg/m2] is an established risk factor for incident radiographic knee OA (ROA). However, the relative contributions…
  • Abstract Number: 1956 • ACR Convergence 2024

    Artificial Intelligence Enhanced Analysis of Nailfold Capillaries by Dermatoscopy in Rheumatology Centers

    Genessis Maldonado1, Eduardo Ramos-ibañez2, Borja del Carmelo Gracia-Tello3, Radic Mislav4 and Tracy Frech1, 1Vanderbilt University Medical Center, Nashville, TN, 2University of Zaragoza, Zaragoza, Spain, 3Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain, 4University Hospital of Split, Split, Croatia

    Background/Purpose: The use of dermatoscopes in rheumatology has been established for several years. However, the application of artificial intelligence for the detection of abnormalities in…
  • Abstract Number: 0462 • ACR Convergence 2024

    Circulating Mediators of Endothelial Dysfunction as Predictors of Incident Heart Failure in Rheumatoid Arthritis

    Tate Johnson1, Michael Duryee1, Carlos Hunter1, Punyasha Roul2, Joshua Baker3, grant Cannon4, Beth Wallace5, Paul Monach6, Andreas Reimold7, Gail Kerr8, Isaac Smith9, John Richards10, Katherine Wysham11, Gary Kunkel12, Iris Lee13, Daniel Anderson14, Geoffrey Thiele1, Ted Mikuls1 and Bryant England1, 1University of Nebraska Medical Center, Omaha, NE, 2UNMC, Omaha, NE, 3University of Pennsylvania, Philadelphia, PA, 4University of Utah and Salt Lake City VA, Salt Lake City, UT, 5Michigan Medicine, VA Ann Arbor Healthcare System, Ann Arbor, MI, 6VA Boston Healthcare System, Boston, MA, 7Dallas VA Medical Center, Dallas, TX, 8Washington DC VAMC/Georgetown and Howard Universities, Washington, DC, 9Duke University Hospital, Durham, NC, 10Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, 11VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA, 12University of Utah and George E Wahlen VAMC, Salt Lake City, UT, 13Washington University in St Louis, Saint Louis, MO, 14University of Nebraska Medical Center, Durham, NC

    Background/Purpose: Endothelial dysfunction, leading to myocardial inflammation and dysfunction, may drive a heightened risk of heart failure (HF) in people with rheumatoid arthritis (RA). Circulating…
  • Abstract Number: 1202 • ACR Convergence 2024

    Harnessing MicroRNA and Machine/Deep Learning for Early Prediction of Knee Osteoarthritis Structural Progression

    Afshin Jamshidi1, Osvaldo Espin-Garcia2, Thomas G. Wilson3, Ian Loveless3, Jean-Pierre Pelletier1, Amanda Ali4 and Johanne Martel-Pelletier1, 1Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, 2Department of Epidemiology and Biostatistics, University of Western Ontario; Dalla Lana School of Public Health and Department of Statistical Sciences, University of Toronto; Department of Biostatistics, Schroeder Arthritis Institute; Krembil Research Institute, University Health Network, Toronto, ON, Canada, 3Henry Ford Health + Michigan State University Health Sciences, Detroit, MI, 4Henry Ford Health + Michigan State University Health Sciences; Center for Molecular Medicine and Genetics, Wayne State University, Montreal, QC, Canada

    Background/Purpose: The development of knee osteoarthritis (OA) is generally characterized by a slow evolution. However, its progression and severity may occur rapidly in some individuals.…
  • Abstract Number: 2018 • ACR Convergence 2024

    Non-adherence to Urate Lowering Therapy in Gout After 5 Years Is Related to Poor Outcomes – Results from the NOR-Gout Study

    Tillmann Uhlig1, Lars F Karoliussen1, Joseph Sexton2, Sella A. Provan2, Espen A. Haavardsholm3, Nicola Dalbeth4 and Hilde B Hammer1, 1Diakonhjemmet Hospital, Oslo, Norway, 2Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway, Oslo, Norway, 3Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway, and University of Oslo (UiO), Institute of Clinical Medicine, Oslo, Norway, Oslo, Norway, 4University of Auckland, Auckland, New Zealand

    Background/Purpose: People with gout need to adhere to medication over time to achieve good outcomes. We assessed self-reported adherence to medication with urate lowering therapy…
  • Abstract Number: 0469 • ACR Convergence 2024

    SCORE2 Is Superior to SCORE in Predicting the Presence of Carotid Plaques and Intima-media Thickness in Rheumatoid Arthritis Patients: A Cross-sectional Study with Carotid Ultrasound

    Cristina Campos Fernández1, Jorge Juan Fragío Gil2, Roxana González Mazario3, Pablo Martínez Calabuig4, Laura Salvador Maicas5, Mireia Lucía Sanmartín Martínez6, Iván Jesús Lorente Betanzos6, Clara Molina Almela6, juan José Lerma Garrido7, Amalia Rueda3 and Jose A Román-Ivorra8, 1Escuela de Doctorado, Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain, 2Hospital General Universitario, Valencia, Comunidad Valenciana, Spain, 3Hospital General de Valencia, Valencia, Comunidad Valenciana, Spain, 4HOSPITAL GENERAL UNIVERSITARIO VALENCIA SPAIN, Ontinyent, Comunidad Valenciana, Spain, 5Consorcio Hospital General Universitario de Valencia, Castellón de la Plana, Comunidad Valenciana, Spain, 6Consorcio Hospital General Universitario de Valencia, Valencia, Comunidad Valenciana, Spain, 7Hospital General Universitario Valencia, Valencia, Comunidad Valenciana, Spain, 8Hospital Universitari i Politècnic la Fe, Valencia, Comunidad Valenciana, Spain

    Background/Purpose: Rheumatoid arthritis (RA) escalates the risk of premature mortality, predominantly through cardiovascular diseases. Although SCORE and its updated version, SCORE2, are employed to assess…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 12
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology